Martínez RD, Fernández LE, Acosta RA

Language: Spanish
References: 10
Page: 74-80
PDF size: 345.65 Kb.

ABSTRACT

Background: Paraneoplastic dermatoses are rare, and about them there are no previous studies in the Cienfuegos province. The timely diagnosis of a possible internal neoplasm sometimes depends on its correct recognition.
Objective: to describe the behavior of paraneoplastic dermatoses in cancer patients.
Methods: descriptive study, carried out in patients with malignant neoplasms, treated from June 2016 to December 2017, at the Dr. Gustavo Aldereguía Lima Hospital, in Cienfuegos. Fifty-nine patients with paraneoplastic dermatosis were included, for which the type of dermatosis, time of appearance and its association with each type of neoplasia were analyzed. The information was obtained through the clinical dermatological examination and the medical records.
Results: 17 types of paraneoplastic dermatoses were identified, highlighting the Leser Trélat sign (21.0%), followed by Sweet's syndrome (16.1%) and pyoderma gangrenosum (11.3%). In 25 (42.4%) patients these were detected before the diagnosis of neoplasms, among which lymphoma (86.7%) was the most representative, followed by colon and breast neoplasms, although they were also associated with Syndrome of Sweet and a pyoderma gangrenosum.
Conclusion: Recognizing the characteristic lesions of paraneoplastic dermatoses facilitates the early detection of a hidden cancer, whose own manifestations would probably appear months later, even years.

REFERENCES

1. Morán C, Nieto W. Dermatosis paraneoplásica en relación a la detección temprana del cáncer. Rev Med Hered[Internet]. 2019[citado 19/11/2020];30(2):[aprox. 3p]. Disponible en: http://www.scielo.org.pe/scielo.php?script=sci_arttext&pid=S1018-130X2019000200015&lng=es

2. Monestier S, Richard MA. Dermatosis paraneoplásicas. EMC-Dermatología. 2018;52(2):1-17.

3. Calle A, Escutia B, Botella R. Dermatosis paraneoplásicas y metástasis cutáneas. En: Conejo J, Moreno JC, Camacho FM. Manual de dermatología Vol. 2. España: Grupo Aula Médica; 2018. p. 1334-53.

4. Santa C, Parga MI, Ruiz MC, Martínez W, Pérez C, Galeano E. Pioderma gangrenoso paraneoplásico en una paciente con recaída de leucemia mieloide aguda. CES Med[Internet]. 2020[citado 19/11/2020];34(2):[aprox. 14p]. Disponible en: https://revistas.ces.edu.co/index.php/medicina/article/view/2946/3308

5. Portillo RM, Padilla E, Molina MN, Redondo E, Osorio J. Dermatomiositis como primera manifestación de síndrome paraneoplásico, en cáncer de vejiga. Rev Hisp Cienc Salud[Internet]. 2018[citado 19/11/2020];4(2):[aprox. 10p]. Disponible en: https://dialnet.unirioja.es/descarga/articulo/6786509.pdf

6. Carrera F, Pérez P, Padilla T, Barbar J, Sarmiento A, Rodríguez J, Terraza D, Salazar A, Maldera S. Síndrome de Bazex: Acroqueratosis Paraneoplásica Secundaria a Cáncer de Próstata. Medicina Interna[Internet]. 2018[citado 19/11/2020];34(1):[aprox. 8p]. Disponible en: https://www.svmi.web.ve/ojs/index.php/medint/article/view/459/451

7. Uh I, Molina AL, Eljure N, Aceves JE. Eritroderma associated to gastric adenocarcinoma. Dermatol Rev Mex[Internet]. 2018[citado 19/11/2020];62(3):[aprox. 7p]. Disponible en: https://dermatologiarevistamexicana.org.mx/descarga/3370/

8. Rodríguez G, Vargas E, Abaúnza C, Cáceres S. Eritema necrolítico migratorio y glucagonoma pancreático. Biomédica[Internet]. 2016[citado 19/11/2020];36(2):[aprox. 14p]. Disponible en: https://www.redalyc.org/pdf/843/84345718003.pdf

9. Blanco A. Valor pronóstico de las lesiones cutáneas en el desarrollo de un cáncer sistémico. Análisis descriptivo y de supervivencia[Internet]. Valladolid: Universidad de Valladolid; 2019[citado 19/11/2020]. Disponible en: Disponible en: https://uvadoc.uva.es/bitstream/handle/10324/36421/TFG-M-M1455.pdf?sequence=1&isAllowed=y

10. Guerra LF, Oyarzabal A, Oyarzabal A. Eritrodermia y mieloma. Informe de caso. Acta Médica del Centro[Internet]. 2020[citado 19/11/2020];14(40):[aprox. 6p]. Disponible en: http://www.revactamedicacentro.sld.cu/index.php/amc/article/view/1077/1386